Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96

European Journal of Neuroscience

Volumn 39, Issue 6, 2014, Pages 1026-1041

  Ubhi, Kiren ^a   Rockenstein, Edward ^a   Kragh, Christine ^b   Inglis, Chandra ^a   Spencer, Brian ^a   Michael, Sarah ^a   Mante, Michael ^a   Adame, Anthony ^a   Galasko, Douglas ^a   Masliah, Eliezer ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human; Mouse; Neurodegeneration; Transgenic

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; MICRORNA; MICRORNA 96; TAURINE TRANSPORTER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFUSE LEWY BODY DISEASE; DISEASE MODEL; DOWN REGULATION; GENE TARGETING; HUMAN; HUMAN TISSUE; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RNA ANALYSIS; SHY DRAGER SYNDROME; UPREGULATION;

HUMAN; MOUSE; NEURODEGENERATION; TRANSGENIC;

ALZHEIMER DISEASE; ANIMALS; CASE-CONTROL STUDIES; EXCITATORY AMINO ACID TRANSPORTER 3; GENE EXPRESSION PROFILING; HUMANS; HUNTINGTON DISEASE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICRORNAS; PARKINSON DISEASE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 84896109636     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12444     Document Type: Article

References (117)

1. Ambros, V. (2001) microRNAs: tiny regulators with great potential. Cell, 107, 823-826.
2. (-)-dependent TauT (SLC6A6). J. Physiol., 587, 731-744.
3. Aoyama, K., Watabe, M. & Nakaki, T. (2012) Modulation of neuronal glutathione synthesis by EAAC1 and its interacting protein GTRAP3-18. Amino Acids, 42, 163-169.
4. Asikainen, S., Rudgalvyte, M., Heikkinen, L., Louhiranta, K., Lakso, M., Wong, G. & Nass, R. (2010) Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models. J. Mol. Neurosci., 41, 210-218.
5. Barbato, C., Ruberti, F. & Cogoni, C. (2009) Searching for MIND: microRNAs in neurodegenerative diseases. J. Biomed. Biotechnol., 2009, 871313.
6. Beal, M.F., Lang, A.E. & Ludolph, A.C. (2005) Neurodegenerative Diseases: Neurobiology, Pathogenesis, and Therapeutics. Cambridge University Press, Cambridge.
7. Berezikov, E. (2011) Evolution of microRNA diversity and regulation in animals. Nat. Rev. Genet., 12, 846-860.
8. Biswas, M. & Chan, J.Y. (2010) Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol. Appl. Pharm., 244, 16-20.
9. Cairns, N.J., Atkinson, P.F., Hanger, D.P., Anderton, B.H., Daniel, S.E. & Lantos, P.L. (1997) Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci. Lett., 230, 49-52.
10. Chen, N.H., Reith, M.E. & Quick, M.W. (2004) Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflug. Arch. Eur. J. Phy., 447, 519-531.
11. Chen, R.X., Xia, Y.H., Xue, T.C. & Ye, S.L. (2011) Suppression of microRNA-96 expression inhibits the invasion of hepatocellular carcinoma cells. Mol. Med. Rep., 5, 800-804.
12. Chin, J., Palop, J.J., Puoliväli, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E. & Mucke, L. (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci., 25, 9694-9703.
13. Clough, R.L., Dermentzaki, G. & Stefanis, L. (2009) Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219. J. Neurochem., 110, 1479-1490.
14. Delay, C. & Hébert, S.S. (2011) MicroRNAs and Alzheimer's disease mouse models: current insights and future research avenues. Int. J. Alzheimers Dis., 2011, 894938.
15. Dirson, G., Desjardins, P., Tannenberg, T., Dodd, P. & Butterworth, R.F. (2002) Selective loss of expression of glutamate GluR2/R3 receptor subunits in cerebellar tissue from a patient with olivopontocerebellar atrophy. Metab. Brain Dis., 17, 77-82.
16. Doxakis, E. (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J. Biol. Chem., 285, 12726-12734.
17. Enciu, A.M., Popescu, B.O. & Gheorghisan-Galateanu, A. (2011) MicroRNAs in brain development and degeneration. Mol. Biol. Rep., 39, 2243-2252.
18. Featherstone, D.E. (2011) Glial solute carrier transporters in Drosophila and mice. Glia, 59, 1351-1363.
19. Flunkert, S., Hierzer, M., Löffler, T., Rabl, R., Neddens, J., Duller, S., Schofield, E.L., Ward, M.A., Posch, M., Jungwirth, H., Windisch, M. & Hutter-Paier, B. (2013) Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model. Neurodegener. Dis., 11, 194-205.
20. Frühbeis, C., Fröhlich, D., Kuo, W.P., Amphornrat, J., Thilemann, S., Saab, A.S., Kirchhoff, F., Möbius, W., Goebbels, S., Nave, K.A., Schneider, A., Simons, M., Klugmann, M., Trotter, J. & Krämer-Albers, E.M. (2013) Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol., 11, e1001604.
21. Gambari, R., Fabbri, E., Borgatti, M., Lampronti, I., Finotti, A., Brognara, E., Bianchi, N., Manicardi, A., Marchelli, R. & Corradini, R. (2011) Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem. Pharmacol., 82, 1416-1429.
22. Gao, F.B. (2010) Context-dependent functions of specific microRNAs in neuronal development. Neural Dev., 5, 25.
23. Geekiyanage, H. & Chan, C. (2011) MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci., 31, 14820-14830.
24. Gehrke, S., Imai, Y., Sokol, N. & Lu, B. (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature, 466, 637-641.
25. Gillardon, F., Mack, M., Rist, W., Schnack, C., Lenter, M., Hildebrandt, T. & Hengerer, B. (2008) MicroRNA and proteome expression profiling in early-symptomatic alpha-synuclein(A30P)-transgenic mice. Proteom. Clin. Appl., 2, 697-705.
26. Gilman, S., Low, P.A., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C.J., Kaufmann, H., Klockgether, T., Lang, A.E., Lantos, P.L., Litvan, I., Mathias, C.J., Oliver, E., Robertson, D., Schatz, I. & Wenning, G.K. (1999) Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci., 163, 94-98.
27. Go, R.C., Perry, R.T., Wiener, H., Bassett, S.S., Blacker, D., Devlin, B. & Sweet, R.A. (2005) Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. Am. J. Med. Genet. B., 139B, 28-32.
28. Goffart, S. & Wiesner, R.J. (2003) Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp. Physiol., 88, 33-40.
29. Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P. & Bartel, D.P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell, 27, 91-105.
30. Han, Y., Chen, J., Zhao, X., Liang, C., Wang, Y., Sun, L., Jiang, Z., Zhang, Z., Yang, R., Chen, J. Li, Z., Tang, A., Li, X., Ye, J., Guan, Z., Gui, Y. & Cai, Z. (2011) MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE, 6, e18286.
31. Hannafon, B.N. & Ding, W.Q. (2013) Intercellular communication by exosome-derived microRNAs in cancer. Int. J. Mol. Sci., 14, 14240-14269.
32. Harraz, M.M., Dawson, T.M. & Dawson, V.L. (2011) MicroRNAs in Parkinson's disease. J. Chem. Neuroanat., 42, 127-130.
33. Hashida, H., Goto, J., Zhao, N., Takahashi, N., Hirai, M., Kanazawa, I. & Sakaki, Y. (1998) Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA). Genomics, 54, 50-58.
34. Hébert, S.S., Wang, W.X., Zhu, Q. & Nelson, P.T. (2013) A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J. Alzheimers Dis., 35, 335-348.
35. Hediger, M.A., Romero, M.F., Peng, J.B., Rolfs, A., Takanaga, H. & Bruford, E.A. (2004) The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflug. Arch. Eur. J. Phy., 447, 465-468.
36. Iacobazzi, V., Infantino, V., Convertini, P., Vozza, A., Agrimi, G. & Palmieri, F. (2009) Transcription of the mitochondrial citrate carrier gene: identification of a silencer and its binding protein ZNF224. Biochem. Bioph. Res. Co., 386, 186-191.
37. Jaiswal, A.K. (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Bio. Med., 36, 1199-1207.
38. Jensen, K.P. & Covault, J. (2011) Human miR-1271 is a miR-96 paralog with distinct non-conserved brain expression pattern. Nucleic Acids Res., 39, 701-711.
39. Juhila, J., Sipilä, T., Icay, K., Nicorici, D., Ellonen, P., Kallio, A., Korpelainen, E., Greco, D. & Hovatta, I. (2011) MicroRNA expression profiling reveals miRNA families regulating specific biological pathways in mouse frontal cortex and hippocampus. PLoS ONE, 6, e21495.
40. Junn, E. & Mouradian, M.M. (2011) MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol. Therapeut., 133, 142-150.
41. Junn, E., Lee, K.W., Jeong, B.S., Chan, T.W., Im, J.Y. & Mouradian, M.M. (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl. Acad. Sci. USA, 106, 13052-13057.
42. Kahle, P.J., Neumann, M., Ozmen, L., Muller, V., Jacobsen, H., Spooren, W., Fuss, B., Mallon, B., Macklin, W.B., Fujiwara, H., Hasegawa, M., Iwatsubo, T., Kretzschmar, H.A. & Haass, C. (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep., 3, 583-588.
43. Kanai, Y. & Hediger, M.A. (2004) The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflug. Arch. Eur. J. Phy., 447, 469-479.
44. Kanao, T., Venderova, K., Park, D.S., Unterman, T., Lu, B. & Imai, Y. (2010) Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila. Hum. Mol. Genet., 19, 3747-3758.
45. Kasinski, A.L. & Slack, F.J. (2011) Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer, 11, 849-864.
46. Kim, J., Inoue, K., Ishii, J., Vanti, W.B., Voronov, S.V., Murchison, E., Hannon, G. & Abeliovich, A. (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science, 317, 1220-1224.
47. Krek, A., Grün, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M. & Rajewsky, N. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
48. Kristensen, A.S., Andersen, J., Jorgensen, T.N., Sørensen, L., Eriksen, J., Loland, C.J., Strømgaard, K. & Gether, U. (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev., 63, 585-640.
49. Kurata, T., Kametaka, S., Ohta, Y., Morimoto, N., Deguchi, S., Deguchi, K., Ikeda, Y., Takao, Y., Ohta, T., Manabe, Y., Sato, S. & Abe, K. (2011) PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Intern. Med., 50, 2775-2781.
50. Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S. & Zucman-Rossi, J. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47, 1955-1963.
51. Lantos, P.L. & Papp, M.I. (1994) Cellular pathology of multiple system atrophy: a review. J. Neurol. Neurosur. Ps., 57, 129-133.
52. Lee, S.T., Chu, K., Im, W.S., Yoon, H.J., Im, J.Y., Park, J.E., Park, K.H., Jung, K.H., Lee, S.K., Kim, M. & Roh, J.K. (2011) Altered microRNA regulation in Huntington's disease models. Exp. Neurol., 227, 172-179.
53. Lewis, B.P., Burge, C.B. & Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
54. Li, Y.Y., Cui, J.G., Hill, J.M., Bhattacharjee, S., Zhao, Y. & Lukiw, W.J. (2011) Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci. Lett., 487, 94-98.
55. Loscher, C.J., Hokamp, K., Kenna, P.F., Ivens, A.C., Humphries, P., Palfi, A. & Farrar, G.J. (2007) Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. Genome Biol., 8, R248.
56. Loscher, C.J., Hokamp, K., Wilson, J.H., Li, T., Humphries, P., Farrar, G.J. & Palfi, A. (2008) A common microRNA signature in mouse models of retinal degeneration. Exp. Eye Res., 87, 529-534.
57. Lukiw, W.J. (2007) Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport, 18, 297-300.
58. Ma, L., Huang, Y., Zhu, W., Zhou, S., Zhou, J., Zeng, F., Liu, X., Zhang, Y. & Yu, J. (2011) An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. PLoS ONE, 6, e26502.
59. Manolopoulos, K.N., Klotz, L.O., Korsten, P., Bornstein, S.R. & Barthel, A. (2010) Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress. Mol. Psychiatr., 15, 1046-1052.
60. Margis, R. Margis, R. & Rieder, C.R. (2011) Identification of blood microRNAs associated to Parkinson's disease. J. Biotechnol., 152, 96-101.
61. Martino, S., di Girolamo, I., Orlacchio, A., Datti, A. & Orlacchio, A. (2009) MicroRNA implications across neurodevelopment and neuropathology. J. Biomed. Biotechnol., 2009, 654346.
62. Maynard, T.M., Meechan, D.W., Dudevoir, M.L., Gopalakrishna, D., Peters, A.Z., Heindel, C.C., Sugimoto, T.J., Wu, Y., Lieberman, J.A. & Lamantia, A.S. (2008) Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. Mol. Cell. Neurosci., 39, 439-451.
63. de Mena, L., Cardo, L.F., Coto, E., Miar, A., Díaz, M., Corao, A.I., Alonso, B., Ribacoba, R., Salvador, C., Menéndez, M., Moriś, G. & Alvarez, V. (2010) FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients. Neurosci. Lett., 479, 22-25.
64. Mihelich, B.L., Khramtsova, E.A., Arva, N., Vaishnav, A., Johnson, D.N., Giangreco, A.A., Martens-Uzunova, E., Bagasra, O., Kajdacsy-Balla, A. & Nonn, L. (2011) miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J. Biol. Chem., 286, 44503-44511.
65. Monsalve, M. & Olmos, Y. (2011) The complex biology of FOXO. Curr. Drug Targets, 12, 1322-1350.
66. Morciano, P., Carrisi, C., Capobianco, L., Mannini, L., Burgio, G., Cestra, G., De Benedetto, G.E., Corona, D.F., Musio, A. & Cenci, G. (2009) A conserved role for the mitochondrial citrate transporter Sea/SLC25A1 in the maintenance of chromosome integrity. Hum. Mol. Genet., 18, 4180-4188.
67. Moss, E.G. (2002) MicroRNAs: hidden in the genome. Curr. Biol., 12, R138-R140.
68. Nagaishi, M., Yokoo, H. & Nakazato, Y. (2011) Tau-positive glial cytoplasmic granules in multiple system atrophy. Neuropathology, 31, 299-305.
69. Navon, R., Wang, H., Steinfeld, I., Tsalenko, A., Ben-Dor, A. & Yakhini, Z. (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE, 4, e8003.
70. Nymark, P., Guled, M., Borze, I., Faisal, A., Lahti, L., Salmenkivi, K., Kettunen, E., Anttila, S. & Knuutila, S. (2011) Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer. Gene. Chromosome Can., 50, 585-597.
71. Otis, T.S., Brasnjo, G., Dzubay, J.A. & Pratap, M. (2004) Interactions between glutamate transporters and metabotropic glutamate receptors at excitatory synapses in the cerebellar cortex. Neurochem. Int., 45, 537-544.
72. Pérez-Navarro, E., Arenas, E., Marco, S. & Alberch, J. (1999) Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Eur. J. Neurosci., 11, 241-249.
73. Pichardo-Casas, I., Goff, L.A., Swerdel, M.R., Athie, A., Davila, J., Ramos-Brossier, M., Lapid-Volosin, M., Friedman, W.J., Hart, R.P. & Vaca, L. (2012) Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation. Brain Res., 1436, 20-33.
74. Pierce, M.L., Weston, M.D., Fritzsch, B., Gabel, H.W., Ruvkun, G. & Soukup, G.A. (2008) MicroRNA-183 family conservation and ciliated neurosensory organ expression. Evol. Dev., 10, 106-113.
75. Rehmsmeier, M., Steffen, P., Hochsmann, M. & Giegerich, R. (2004) Fast and effective prediction of microRNA/target duplexes. RNA, 10, 1507-1517.
76. Ren, Q., Chen, K. & Paulsen, I.T. (2007) TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic Acids Res., 35, D274-D279.
77. Roberson, E.D., Halabisky, B., Yoo, J.W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G.Q., Palop, J.J., Noebels, J.L. & Mucke, L. (2011) Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J. Neurosci., 31, 700-711.
78. Rockenstein, E., Mallory, M., Mante, M., Sisk, A. & Masliaha, E. (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J. Neurosci. Res., 66, 573-582.
79. Rockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C.W., Lang, I. & Masliah, E. (2002) Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J. Neurosci. Res., 68, 568-578.
80. Roshan, R., Ghosh, T., Scaria, V. & Pillai, B. (2009) MicroRNAs: novel therapeutic targets in neurodegenerative diseases. Drug Discov. Today, 14, 1123-1129.
81. Santosh, P.S., Arora, N., Sarma, P., Pal-Bhadra, M. & Bhadra, U. (2009) Interaction map and selection of microRNA targets in Parkinson's disease-related genes. J. Biomed. Biotechnol., 2009, 363145.
82. Satoh, J.I. (2011) Molecular network of microRNA targets in Alzheimer's disease brains. Exp. Neurol., 235, 436-446.
83. Scales, T.M., Derkinderen, P., Leung, K.Y., Byers, H.L., Ward, M.A., Price, C., Bird, I.N., Perera, T., Kellie, S., Williamson, R., Anderton, B.H. & Reynolds, C.H. (2011) Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn. Mol. Neurodegener., 6, 12.
84. Schaefer, A., Jung, M., Miller, K., Lein, M., Kristiansen, G., Erbersdobler, A. & Jung, K. (2010a) Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp. Mol. Med., 42, 749-758.
85. Schaefer, A., Jung, M., Mollenkopf, H.J., Wagner, I., Stephan, C., Jentzmik, F., Miller, K., Lein, M., Kristiansen, G. & Jung, K. (2010b) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer, 126, 1166-1176.
86. Schonrock, N., Ke, Y.D., Humphreys, D., Staufenbiel, M., Ittner, L.M., Preiss, T. & Götz, J. (2010) Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS ONE, 5, e11070.
87. Seol, W. (2010) Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease. BMB Rep., 43, 233-244.
88. Sethi, P. & Lukiw, W.J. (2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett., 459, 100-104.
89. Sethupathy, P., Megraw, M. & Hatzigeorgiou, A.G. (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods, 3, 881-886.
90. Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T. & Satoh, J. (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropath. Appl. Neuro., 36, 320-330.
91. Shults, C.W., Rockenstein, E., Crews, L., Adame, A., Mante, M., Larrea, G., Hashimoto, M., Song, D., Iwatsubo, T., Tsuboi, K. & Masliah, E. (2005a) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J. Neurosci., 25, 10689-10699.
92. Shults, C.W., Rockenstein, E., Crews, L., Adame, A., Mante, M., Larrea, G., Hashimoto, M., Song, D., Iwatsubo, T., Tsuboi, K. & Masliah, E. (2005b) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J. Neurosci., 25, 10689-10699.
93. Siegel, G., Saba, R. & Schratt, G. (2011) microRNAs in neurons: manifold regulatory roles at the synapse. Curr. Opin. Genet. Dev., 21, 491-497.
94. Smith, K.E., Borden, L.A., Wang, C.H., Hartig, P.R., Branchek, T.A. & Weinshank, R.L. (1992) Cloning and expression of a high affinity taurine transporter from rat brain. Mol. Pharmacol., 42, 563-569.
95. Smith, B., Treadwell, J., Zhang, D., Ly, D., McKinnell, I., Walker, P.R. & Sikorska, M. (2010) Large-scale expression analysis reveals distinct microRNA profiles at different stages of human neurodevelopment. PLoS ONE, 5, e11109.
96. Soma, H., Yabe, I., Takei, A., Fujiki, N., Yanagihara, T. & Sasaki, H. (2008) Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes. Movement Disord., 23, 1161-1167.
97. Tomi, M., Tajima, A., Tachikawa, M. & Hosoya, K. (2008) Function of taurine transporter (Slc6a6/TauT) as a GABA transporting protein and its relevance to GABA transport in rat retinal capillary endothelial cells. Biochim. Biophys. Acta, 1778, 2138-2142.
98. Torp, R., Hoover, F., Danbolt, N.C., Storm-Mathisen, J. & Ottersen, O.P. (1997) Differential distribution of the glutamate transporters GLT1 and rEAAC1 in rat cerebral cortex and thalamus: an in situ hybridization analysis. Anat. Embryol., 195, 317-326.
99. Turchinovich, A., Samatov, T.R., Tonevitsky, A.G. & Burwinkel, B. (2013) Circulating miRNAs: cell-cell communication function? Front. Genet., 4, 119.
100. Ubhi, K., Rockenstein, E., Mante, M., Inglis, C., Adame, A., Patrick, C., Whitney, K. & Masliah, E. (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J. Neurosci., 30, 6236-6246.
101. Utsumi, M., Ohno, K., Onchi, H., Sato, K. & Tohyama, M. (2001) Differential expression patterns of three glutamate transporters (GLAST, GLT1 and EAAC1) in the rat main olfactory bulb. Brain Res. Mol. Brain Res., 92, 1-11.
102. Wakabayashi, K. & Takahashi, H. (2006) Cellular pathology in multiple system atrophy. Neuropathology, 26, 338-345.
103. Wang, G., van der Walt, J.M., Mayhew, G., Li, Y.J., Zuchner, S., Scott, W.K., Martin, E.R. & Vance, J.M. (2008) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet., 82, 283-289.
104. Wang, H., Liu, J., Zong, Y., Xu, Y., Deng, W., Zhu, H., Liu, Y., Ma, C., Huang, L., Zhang, L. & Qin, C. (2010) miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res., 1357, 166-174.
105. Wang, L.L., Huang, Y., Wang, G. & Chen, S.D. (2012a) The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target? Med. Hypotheses, 78, 398-401.
106. Wang, Y., Luo, H., Li, Y., Chen, T., Wu, S. & Yang, L. (2012b) hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas. Mol. Med. Rep., 5, 260-265.
107. Warskulat, U., Heller-Stilb, B., Oermann, E., Zilles, K., Haas, H., Lang, F. & Häussinger, D. (2007) Phenotype of the taurine transporter knockout mouse. Method. Enzymol., 428, 439-458.
108. Won, S.J., Yoo, B.H., Brennan, A.M., Shin, B.S., Kauppinen, T.M., Berman, A.E., Swanson, R.A. & Suh, S.W. (2010) EAAC1 gene deletion alters zinc homeostasis and exacerbates neuronal injury after transient cerebral ischemia. J. Neurosci., 30, 15409-15418.
109. Wu, J.H., Gao, Y., Ren, A.J., Zhao, S.H., Zhong, M., Peng, Y.J., Shen, W., Jing, M. & Liu, L. (2012) Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthal. Res., 47, 195-201.
110. Xu, X. (2007) Same computational analysis, different miRNA target predictions. Nat. Methods, 4, 191; author reply 191.
111. Xu, S., Witmer, P.D., Lumayag, S., Kovacs, B. & Valle, D. (2007) MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J. Biol. Chem., 282, 25053-25066.
112. Yamada, Y., Enokida, H., Kojima, S., Kawakami, K., Chiyomaru, T., Tatarano, S., Yoshino, H., Kawahara, K., Nishiyama, K., Seki, N. & Nakagawa, M. (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci., 102, 522-529.
113. Yamakuchi, M. & Lowenstein, C.J. (2009) MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle, 8, 712-715.
114. Yazawa, I., Giasson, B.I., Sasaki, R., Zhang, B., Joyce, S., Uryu, K., Trojanowski, J.Q. & Lee, V.M. (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron, 45, 847-859.
115. Yoshida, M. (2007) Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology, 27, 484-493.
116. Zhu, W., Liu, X., He, J., Chen, D., Hunag, Y. & Zhang, Y.K. (2011) Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer, 11, 393.
117. Zovoilis, A., Agbemenyah, H.Y., Agis-Balboa, R.C., Stilling, R.M., Edbauer, D., Rao, P., Farinelli, L., Delalle, I., Schmitt, A., Falkai, P., Bahari-Javan, S., Burkhardt, S., Sananbenesi, F. & Fischer, A. (2011) microRNA-34c is a novel target to treat dementias. EMBO J., 30, 4299-4308.